Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Holders of 5% or more of LTRN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lantern Pharma Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Lantern Pharma Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Lantern Pharma Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| May 15, 20264:20 PM ET | Bios Equity Partners, LPand 13 others | 13D/A | 4.48%571.3K shares | −4.10 ppfrom 8.58%Below 5% | May 15, 2026 | SEC |
| Feb 23, 20264:37 PM ET | Bios Equity Partners, LPand 13 others | 13D/A | 8.58%960.0K shares | −1.40 ppfrom 9.98% | Feb 20, 2026 | SEC |
| Jun 13, 20257:43 PM ET | Bios Equity Partners, LPand 13 others | 13D/A | 9.98%1.08M shares | – | Jun 12, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lantern Pharma Inc. shares.
No Form 144 notices for Lantern Pharma Inc. are on file.